PARIS/LONDON (Reuters) - French drugmaker Sanofi-Aventis is preparing to sell its own generic version of the blockbuster heart medicine Plavix in France, a company spokesman said on Monday. Plavix, ...

If you’re considering treatment options for managing certain kinds of heart conditions, you may want to learn more about Plavix (clopidogrel). It’s a prescription drug used to reduce the risk of heart ...

News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...

LONDON (MarketWatch) -- Swiss generics firm Schweizerhall Holdings said Friday that it's on the verge of launching a generic version of Plavix, a move that, if successful, could ratchet up the ...

LONDON (Reuters) - Sanofi-Aventis and Bristol-Myers Squibb , which are just recovering from defeating generic competition to their top-selling Plavix drug in the United States, now face a similar ...

LONDON (MarketWatch) -- French pharmaceutical Sanofi-Aventis said Friday that it's evaluating its legal and regulatory options after Schweizerhall Holdings said it's close to launching a generic ...

Clopidogrel is a generic prescription oral tablet that’s used to lower the risk of stroke and heart attack in certain adults. The drug is also available as the brand-name drug Plavix. It’s not known ...

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel. Clopidogrel, currently sold under the brand name Plavix®, ...

Plavix is also given to those who have unstable angina or peripheral artery disease. Using Plavix in combination with aspirin may be more effective in preventing another heart attack, but this will ...

The US Food and Drug Administration (FDA) announced it has approved eleven generic versions of Bristol-Myers Squibb and Sanofi's blockbuster blood-thinner Plavix (clopidogrel bisulfate), marking the ...

After nearly a decade, is it possible that litigation over generic versions of the blood thinner Plavix has finally come to an end Don't bet on it. The U.S. Court of Appeals for the Federal Circuit on ...

A former senior vice-president at Bristol-Myers Squibb has been charged by the US Department of Justice with lying to federal authorities over a deal struck with rival generics maker Apotex. According ...